Jane Wasman Insider Trading $ACOR ACORDA THERAPEUTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jane Wasman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jane Wasman. Jane Wasman is Chief, St. Dev. and Gen. Coun in ACORDA THERAPEUTICS INC ($ACOR) and Exec VP, General Counsel & Sec in ACORDA THERAPEUTICS INC ($ACOR).
Jane Wasman in ACORDA THERAPEUTICS INC
Trading Symbol: ACORIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jane Wasman: Chief, St. Dev. and Gen. Coun, Exec VP, General Counsel & Sec
Holdings: 74,970 shares
Current Value: $1,589,364
Latest Transaction: Mar 19 2012
$ACOR Market Capitalization: $941.09M
$ACOR Previous Close: $21.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jane Wasman in ACORDA THERAPEUTICS INC
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.59 | 200 | 3,118 | 48,315 | 48.5 K to 48.3 K (-0.41 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.60 | 100 | 1,560 | 48,515 | 48.6 K to 48.5 K (-0.21 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.62 | 300 | 4,686 | 48,615 | 48.9 K to 48.6 K (-0.61 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.65 | 100 | 1,565 | 48,915 | 49 K to 48.9 K (-0.20 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.66 | 100 | 1,566 | 49,015 | 49.1 K to 49 K (-0.20 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.67 | 100 | 1,567 | 49,115 | 49.2 K to 49.1 K (-0.20 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.68 | 300 | 4,704 | 49,215 | 49.5 K to 49.2 K (-0.61 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.69 | 400 | 6,276 | 49,515 | 49.9 K to 49.5 K (-0.80 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.70 | 800 | 12,560 | 49,915 | 50.7 K to 49.9 K (-1.58 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.71 | 100 | 1,571 | 50,715 | 50.8 K to 50.7 K (-0.20 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.72 | 900 | 14,148 | 50,815 | 51.7 K to 50.8 K (-1.74 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.73 | 300 | 4,719 | 51,715 | 52 K to 51.7 K (-0.58 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.74 | 200 | 3,148 | 52,015 | 52.2 K to 52 K (-0.38 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.75 | 400 | 6,300 | 52,215 | 52.6 K to 52.2 K (-0.76 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.76 | 300 | 4,728 | 52,615 | 52.9 K to 52.6 K (-0.57 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.77 | 300 | 4,731 | 52,915 | 53.2 K to 52.9 K (-0.56 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.79 | 200 | 3,158 | 53,215 | 53.4 K to 53.2 K (-0.37 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.80 | 200 | 3,160 | 53,415 | 53.6 K to 53.4 K (-0.37 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.85 | 100 | 1,585 | 53,615 | 53.7 K to 53.6 K (-0.19 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.86 | 100 | 1,586 | 53,715 | 53.8 K to 53.7 K (-0.19 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.89 | 100 | 1,589 | 53,815 | 53.9 K to 53.8 K (-0.19 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.90 | 300 | 4,770 | 53,915 | 54.2 K to 53.9 K (-0.55 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.91 | 100 | 1,591 | 54,215 | 54.3 K to 54.2 K (-0.18 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.92 | 100 | 1,592 | 54,315 | 54.4 K to 54.3 K (-0.18 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.95 | 500 | 7,975 | 54,415 | 54.9 K to 54.4 K (-0.91 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.96 | 300 | 4,788 | 54,915 | 55.2 K to 54.9 K (-0.54 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.00 | 400 | 6,400 | 55,215 | 55.6 K to 55.2 K (-0.72 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.90 | 100 | 1,590 | 55,615 | 55.7 K to 55.6 K (-0.18 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.95 | 100 | 1,595 | 55,715 | 55.8 K to 55.7 K (-0.18 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.98 | 200 | 3,196 | 55,815 | 56 K to 55.8 K (-0.36 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.99 | 600 | 9,594 | 56,015 | 56.6 K to 56 K (-1.06 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.00 | 2,130 | 34,080 | 56,615 | 58.7 K to 56.6 K (-3.63 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.01 | 600 | 9,606 | 58,745 | 59.3 K to 58.7 K (-1.01 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.02 | 1,400 | 22,428 | 59,345 | 60.7 K to 59.3 K (-2.30 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.03 | 3,419 | 54,807 | 60,745 | 64.2 K to 60.7 K (-5.33 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.04 | 1,200 | 19,248 | 64,164 | 65.4 K to 64.2 K (-1.84 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.05 | 3,060 | 49,113 | 65,364 | 68.4 K to 65.4 K (-4.47 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.06 | 1,800 | 28,908 | 68,424 | 70.2 K to 68.4 K (-2.56 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.07 | 2,100 | 33,747 | 70,224 | 72.3 K to 70.2 K (-2.90 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.08 | 1,470 | 23,638 | 72,324 | 73.8 K to 72.3 K (-1.99 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.09 | 1,300 | 20,917 | 73,794 | 75.1 K to 73.8 K (-1.73 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.10 | 500 | 8,050 | 75,094 | 75.6 K to 75.1 K (-0.66 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.11 | 621 | 10,004 | 75,594 | 76.2 K to 75.6 K (-0.81 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.12 | 200 | 3,224 | 76,215 | 76.4 K to 76.2 K (-0.26 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.13 | 200 | 3,226 | 76,415 | 76.6 K to 76.4 K (-0.26 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.14 | 300 | 4,842 | 76,615 | 76.9 K to 76.6 K (-0.39 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.15 | 500 | 8,075 | 76,915 | 77.4 K to 76.9 K (-0.65 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.17 | 200 | 3,234 | 77,415 | 77.6 K to 77.4 K (-0.26 %) |